Milrinone   body {font-family: 'Open Sans', sans-serif;} .ui-header .ui-title, .ui-footer .ui-title { margin-right: 0 !important; margin-left: 0 !important; } \* { margin:0px; padding:0px;} .ui-page { background: #f2f2f2 url(bg.jpg); line-height:1.5em;} #home\_link { color:#FFF; text-decoration:none; cursor:pointer; font-family:'AndikaBasicRegular',Arial, sans-serif; font-size:0.9em; margin-left:15%; } #home\_link span {font-size:0.6em;margin-left:15%; color: #D8D8D8; } h1 {font-family:'AndikaBasicRegular'; }

# Milrinone

**Milrinone (Primacor)**  
**Class:** Phosphodiesterase 3 Inhibitor.  
Noncatecholamine, nonglycoside cardiac inotropic agent.  
Bypyridine derivative-like Amrinone.  
Slowly replacing Dobutamine because it does not cause tachycardia.  
More popular than Amrinone because Amrinone can cause thrombocytopenia.  
**Mix:** 20mg in100ml or 50mg in 250mL= 200mcg/mL  
**Doses:**  
**Adult Loading Dose:** IV 50 mcg/kg over 10 min.  
**Maintenance Infusion:**  
0.375-0.75 mcg/kg/min  
If poor kidney function start at 0.2 mcg/kg/min.  
**Peds Loading Dose:** 50 mcg/kg over 10 min.  
**Peds Maintenance Infusion:** 0.5-1mcg/kg/min  
If poor kidney function start at 0.2 mcg/kg/min.  
**Indications**  
Short-term treatment of CHF  
Improves diastolic function in coronary artery bypass surgery.  
To improve a low CI/CO  
Acute LV dysfunction  
Used to increase C.O. and lower vascular resistance after cardiac surgery.  
Basically a good inotropic and vasodilator.  
**CABGs:** Great for coming off pump, however it does decrease the SVR, so you will need to run a vasoconstrictor along with it.  
**MOA:**  
It selectively inhibits peak III cAMP phosphodiesterase isozyme found in cardiac and vascular muscle.  
This activity leads in increase of intracellular ionized calcium and contractile force in heart muscles.  
**Onset of action** (Why we use a loading dose over 10 mins).  
Begins within several minutes following IV administration.  
**Peak effects:** about 10 minutes.  
**Elimination half time:** 2.7 hours  
**Excreted:** 80% unchanged via kidneys.  
Primary route of excretion is via urine.  
**Milrinone (Primacor)** Notes  
Inotrope-increases contractility and cardiac index.  
Potent Pulmonary Vasodilator  
Vasodilator  
Minimal chronotropic  
Decreases capillary wedge pressure.  
Decreases lowers pulmonary artery pressures.  
Enhances relaxation of the left ventricle (lusitropic effect).  
**Adverse Effects**  
arrhythmias (supraventricular and ventricular)  
hypotension  
headache, angina/chest pain  
hypokalemia  
thrombocytopenia  
Milrinone may increase AV conduction and ventricular response in patients with atrial flutter or fibrillation who have not been digitalized.  
**Caution**  
With uncontrolled AFib/Flutter, Milrinone can enhance AV node conduction; consider digitalizing these patients first.  
**Direct Contraindications:**  
Allergic to any ingredient in Milrinone.  
Aortic or pulmonic valvular disease  
PVD  
Recent MI  
  
**Pregnancy-** Category C. It is not known whether Milrinone is harmful to an unborn.

#### Copyright Â© 2012